Federal Circuit Upholds Patent Board’s Rejection of Labcorp’s Genetic Testing Method

Labcorp’s efforts to challenge a decision by the Patent Trial and Appeal Board were met with resistance when Federal Circuit judges declined to overturn the ruling. The disputed decision relates to a patent involving a method for detecting genetic disorders. For more details on Labcorp’s legal maneuvering and the judges’ rationale, the original coverage is available at Law360.